[go: up one dir, main page]

BE893912A - Compositions pharmaceutiques a inhaler - Google Patents

Compositions pharmaceutiques a inhaler

Info

Publication number
BE893912A
BE893912A BE0/208656A BE208656A BE893912A BE 893912 A BE893912 A BE 893912A BE 0/208656 A BE0/208656 A BE 0/208656A BE 208656 A BE208656 A BE 208656A BE 893912 A BE893912 A BE 893912A
Authority
BE
Belgium
Prior art keywords
inhaled
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
BE0/208656A
Other languages
English (en)
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10523464&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE893912(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of BE893912A publication Critical patent/BE893912A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/208656A 1981-07-24 1982-07-22 Compositions pharmaceutiques a inhaler BE893912A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8122846 1981-07-24

Publications (1)

Publication Number Publication Date
BE893912A true BE893912A (fr) 1983-01-24

Family

ID=10523464

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/208656A BE893912A (fr) 1981-07-24 1982-07-22 Compositions pharmaceutiques a inhaler

Country Status (26)

Country Link
US (1) US4590206A (fr)
EP (1) EP0072046B1 (fr)
JP (1) JPS5859914A (fr)
KR (1) KR890002908B1 (fr)
AU (1) AU540826B2 (fr)
BE (1) BE893912A (fr)
CA (1) CA1187415A (fr)
CH (1) CH657273A5 (fr)
DE (1) DE3268533D1 (fr)
DK (1) DK159716C (fr)
FI (1) FI822548L (fr)
FR (1) FR2510405B1 (fr)
GR (1) GR76229B (fr)
HK (1) HK10088A (fr)
HU (1) HU196904B (fr)
IE (1) IE53640B1 (fr)
IL (1) IL66375A0 (fr)
LU (1) LU84291A1 (fr)
MA (1) MA19548A1 (fr)
MY (1) MY8700857A (fr)
NO (1) NO156394C (fr)
NZ (1) NZ201341A (fr)
PH (1) PH22759A (fr)
PT (1) PT75310B (fr)
SG (1) SG68487G (fr)
ZA (1) ZA825222B (fr)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260306A (en) * 1981-07-24 1993-11-09 Fisons Plc Inhalation pharmaceuticals
JP2770970B2 (ja) * 1987-04-09 1998-07-02 フアイソンズ・ピーエルシー ペンタミジンを含有する医薬組成物
US5204113A (en) * 1987-04-09 1993-04-20 Fisons Plc Pharmaceutical compositions containing pentamidine
US5776434A (en) 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5198221A (en) * 1989-05-17 1993-03-30 Fisons Plc Pharmaceutical composition
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
US5376386A (en) * 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
EP0465841A3 (en) * 1990-06-13 1992-10-14 Hoechst Aktiengesellschaft Quick acting pharmaceutical inhalation forms of diuretics
US5228607A (en) * 1991-06-07 1993-07-20 Tvp, Inc. Rack mountable on a trailer hitch ball
DE69332240T2 (de) * 1992-06-12 2003-04-10 Teijin Ltd., Osaka Ultrafeines pulver zur inhalation und dessen herstellung
US6509006B1 (en) * 1992-07-08 2003-01-21 Inhale Therapeutic Systems, Inc. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
DE69332105T2 (de) * 1992-09-29 2003-03-06 Inhale Therapeutic Systems, San Carlos Pulmonale abgabe von aktiven fragmenten des parathormons
US6024090A (en) * 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
US7448375B2 (en) * 1993-01-29 2008-11-11 Aradigm Corporation Method of treating diabetes mellitus in a patient
AU679789B2 (en) * 1993-10-01 1997-07-10 Astra Aktiebolag Process I
IS1736B (is) * 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
MX9603936A (es) 1994-03-07 1997-05-31 Inhale Therapeutic Syst Metodos y composiciones para el suministro pulmonar de insulina.
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
EP0759939B1 (fr) * 1994-05-18 2005-07-20 Nektar Therapeutics Procedes et compositions pour produire des interferons sous forme de poudre seche
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700136D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US5612053A (en) 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
EP0843565A4 (fr) * 1995-05-12 2002-10-16 Genentech Inc Administration d'un aerosol constitue de particules de grandes dimensions, contenant un produit a usage biologique
GB9606677D0 (en) * 1996-03-29 1996-06-05 Glaxo Wellcome Inc Process and device
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
USRE37053E1 (en) 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6503480B1 (en) 1997-05-23 2003-01-07 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US20030203036A1 (en) 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
EP0952821A4 (fr) * 1996-12-31 2006-07-26 Nektar Therapeutics Procedes permettant de secher par pulverisation de suspensions aqueuses de medicaments hydrophobes avec des excipients hydrophiles et compositions preparees selon ces procedes
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
GB9703673D0 (en) * 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
US20030035778A1 (en) * 1997-07-14 2003-02-20 Robert Platz Methods and compositions for the dry powder formulation of interferon
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
WO1999016422A1 (fr) * 1997-09-29 1999-04-08 Inhale Therapeutic Systems, Inc. Preparations stabilisees pour aerosols-doseurs
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
WO1999036095A1 (fr) * 1998-01-13 1999-07-22 Astrazeneca Uk Limited COMPOSITIONS PHARMACEUTIQUES COMPRENANT UN COMPOSE AYANT UNE ACTION D'AGONISTE DOPAMINERGIQUE (D2) ET UN COMPOSE (B) AYANT UNE ACTION β2-ADRENERGIQUE
DE69911209T2 (de) * 1998-04-20 2004-07-01 Cosmo Oil Co. Ltd. Polyester und verfahren zu seiner herstellung
US6451349B1 (en) 1998-08-19 2002-09-17 Quadrant Healthcare (Uk) Limited Spray-drying process for the preparation of microparticles
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US6858199B1 (en) * 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
EP1210067A2 (fr) * 1999-08-25 2002-06-05 Advanced Inhalation Research, Inc. Modulation de liberation a partir de formulations seches en poudre
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
NZ521034A (en) 2000-02-28 2004-08-27 Vectura Ltd Improvements in or relating to the delivery of oral drugs
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
WO2002009669A2 (fr) * 2000-08-01 2002-02-07 Inhale Therapeutic Systems, Inc. Appareil et procede de production de particules a distribution granulometrique etroite et particules ainsi obtenues
SE516555C2 (sv) * 2000-08-04 2002-01-29 Microdrug Ag Elektropulver
FI20002215A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
CA2433335C (fr) * 2000-12-29 2010-04-20 Advanced Inhalation Research, Inc. Particules a liberation prolongee destinees a etre inhalees
US20030125236A1 (en) * 2000-12-29 2003-07-03 Advenced Inhalation Research, Inc. Particles for inhalation having rapid release properties
DE10128779A1 (de) † 2001-06-13 2003-01-02 Boehringer Ingelheim Pharma Verfahren zur Reinigung von Hartgelatinekapseln
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
WO2003020197A1 (fr) 2001-09-05 2003-03-13 Vectura Limited Perfectionnements dans ou ayant trait a l'administration orale de medicaments
EP1992335A1 (fr) 2001-11-01 2008-11-19 Nektar Therapeutics Procédés de séchage par pulvérisation et compositions correspondantes
US20030129250A1 (en) * 2001-11-20 2003-07-10 Advanced Inhalation Research Inc. Particulate compositions for improving solubility of poorly soluble agents
WO2003043585A2 (fr) * 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Compositions particulaires ameliorees destinees a etre administrees par voie pulmonaire
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US20040014679A1 (en) * 2002-02-20 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co., Kg Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereof
JP2005527508A (ja) * 2002-03-07 2005-09-15 ヴェクトゥラ　リミテッド 経口デリバリー用急速溶融多粒子製剤
US7582284B2 (en) * 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
CA2483914A1 (fr) * 2002-05-07 2003-11-20 Nektar Therapeutics Capsules pour inhalateurs a poudre seche et procedes de fabrication et d'utilisation correspondants
AU2003302329B2 (en) 2002-12-30 2010-01-07 Novartis Ag Prefilming atomizer
WO2005025506A2 (fr) * 2003-09-10 2005-03-24 Map Pharmaceuticals, Inc. Formulations d'aerosol pour administrer de la dihydroergotamine a la circulation systemique par voie pulmonaire
US20080213593A1 (en) * 2005-01-21 2008-09-04 President And Fellows Of Harvard College Systems And Methods For Forming Fluidic Droplets Encapsulated In Particles Such As Colloidal Particles
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
DK2120875T3 (en) 2007-02-11 2018-10-22 Map Pharmaceuticals Inc METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO POSSIBLE QUICK PREVENTION OF MIGRANE AT THE MINIMUM OF THE SIDE EFFECT PROFILE
WO2010151804A1 (fr) * 2009-06-26 2010-12-29 Map Pharmaceuticals, Inc. Administration de particules de dihydro-ergotamine mésylate au moyen d'un inhalateur-doseur
KR101699574B1 (ko) 2009-12-09 2017-01-24 아사히 가라스 가부시키가이샤 Ｅｕｖ 리소그래피용 반사층이 형성된 기판, ｅｕｖ 리소그래피용 반사형 마스크 블랭크, ｅｕｖ 리소그래피용 반사형 마스크, 및 그 반사층이 형성된 기판의 제조 방법
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
CA2869849A1 (fr) 2012-04-13 2013-10-17 Glaxosmithkline Intellectual Property Development Limited Particules agregees comprenant des particules de medicament nanoparticulaires de bromure d'umeclidinium, de trifenatate de vilanterol et de furoate de fluticasone
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
GB1569611A (en) * 1976-01-23 1980-06-18 Fisons Ltd Pelletised or granular medicament formulation
GB1520248A (en) * 1975-07-24 1978-08-02 Fisons Ltd Sodium cromoglycate containing medicament
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
IE45260B1 (en) * 1976-01-23 1982-07-28 Fisons Ltd Pelletised or granular medicament formulation
GB1549229A (en) * 1976-09-23 1979-08-01 Fisons Ltd High density sodium cromoglycate

Also Published As

Publication number Publication date
DK325982A (da) 1983-01-25
NZ201341A (en) 1985-05-31
IE821770L (en) 1983-01-24
MA19548A1 (fr) 1983-04-01
IE53640B1 (en) 1989-01-04
CH657273A5 (fr) 1986-08-29
KR840000226A (ko) 1984-02-18
SG68487G (en) 1988-02-19
ZA825222B (en) 1983-05-25
DK159716C (da) 1991-04-29
PT75310A (en) 1982-08-01
PT75310B (en) 1985-11-29
AU540826B2 (en) 1984-12-06
FI822548L (fi) 1983-01-25
HU196904B (en) 1989-02-28
JPS5859914A (ja) 1983-04-09
LU84291A1 (fr) 1983-02-07
DE3268533D1 (en) 1986-02-27
JPH0468285B2 (fr) 1992-11-02
FR2510405A1 (fr) 1983-02-04
IL66375A0 (en) 1982-11-30
GR76229B (fr) 1984-08-04
NO156394B (no) 1987-06-09
FR2510405B1 (fr) 1985-07-26
PH22759A (en) 1988-12-12
AU8635582A (en) 1983-02-10
DK159716B (da) 1990-11-26
NO156394C (no) 1987-09-16
US4590206A (en) 1986-05-20
NO822556L (no) 1983-01-25
MY8700857A (en) 1987-12-31
CA1187415A (fr) 1985-05-21
HK10088A (en) 1988-02-12
EP0072046B1 (fr) 1986-01-15
EP0072046A1 (fr) 1983-02-16
KR890002908B1 (ko) 1989-08-11
FI822548A0 (fi) 1982-07-20

Similar Documents

Publication Publication Date Title
BE893912A (fr) Compositions pharmaceutiques a inhaler
ES506585A0 (es) Un dispositivo para facilitar la inhalacion oral de medica- mentos en forma de polvo
DK304582A (da) Dosisinhalator
GB8326878D0 (en) Administering medicaments to patients
GB8602264D0 (en) Administering medicaments to patients
IL58209A0 (en) Medicament inhaler
GB2042888B (en) Preparation for administration to the mucosa of the oral or nasal cavity
DK187678A (da) Oral pulverinhalator
MY8400055A (en) Nasal pharmaceutical compositions
MY8600471A (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa and method for administration thereof
DK247581A (da) Inhaleringsapparat til pulveriserede laegemidler
BE894725A (fr) Perfectionnements apportes a un steroide et compositions pharmaceutiques qui le contiennent
BE833394A (fr) Composition pharmaceutique destinee a faciliter l'accouchement
IT1221041B (it) Composizione farmaceutica a cessione prolungata e procedimento per prepararla
IL57876A (en) Pharmaceutical compositions of polysaccharide gums
BE890669A (fr) Compositions fongicides aqueuses et leur preparation
FR2527078B1 (fr) Compositions pharmaceutiques anti-ulceres
GB1545039A (en) Oral anti-diabetic drug composition
CY1490A (en) Improvements in or relating to nasal pharmaceutical compositions
FR2505824B1 (fr) Derives d'isoprenylamine et leur application a des compositions pharmaceutiques
IT8221120A0 (it) Composizione farmaceutica per combattere l'aggregazione delle piastrine.
BE892709A (fr) Nouvelles compositions pharmaceutiques topiques
MY8700766A (en) Improvements in or relating to nasal pharmaceutical compositions
IT7968642A0 (it) Composti e composizioni farmaceutiche inalabili ad azione mucolitica
DE3050005A1 (de) Breath actuated devices for administering powdered medicaments

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FISONS PLC

Effective date: 19940731